FullPAC Announces GOTV Campaign Strategist of the Year GlobeNewswire December 15, 2025 Manny Alvarez Achieved a 77.14% Win Rate for Clients in 2025 Mr. Alvarez's Bilingual Talent Helped Secure Victories for 27 out of 35 Campaign Clients that Implemented GOTV's Voter Turnout Plan FullPAC Currently Intends to List on Nasdaq Under Ticker Symbol “GOTV,” Subject […]

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 15, 2025 CORAL GABLES, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced

Dilon Technologies, a leading provider of medical devices, has gained FDA approval for its MarginProbe® 2 system and is announcing its launch in the U.S. This is the next-generation device for real-time intraoperative margin assessment in breast cancer surgery. MarginProbe® 2 is designed to help surgeons achieve greater precision during breast-conserving surgeries, reducing the need

The prestigious Italian Wine Ambassador Certification Course at Vinitaly International Academy(VIA)will take place in Verona on 15-19 April, 2026. The course is open to international wine students and professionals and consists of four days of in-person lectures, masterclasses and tasting sessionsfollowed on the fifth day by a final exam. Those who successfully complete the exam

Collaboration Aims to Establish Sustainable Access to a Newly Approved Therapy Targeting a Rare Immunodeficiency, Filling Urgent Gap Left by For-Profit Efforts Orphan Therapeutics Accelerator(OTXL), a patient-centered non-profit biotech focused on bringing promising clinical-stage treatments for ultra-rare conditions to patients, and Fondazione Telethon(FT), an Italian non-profit with a 30-year+ legacy of advancing research on rare

TUCSON, AZ / ACCESS Newswire / December 15, 2025 / Applied Energetics, Inc. ("AE") (OTCQB:AERG), a leader in ultrashort pulse laser (USPL) and directed-energy technologies, today announced the completion of its first outdoor testing event of the company’s next-generation USPL laser subsystem. This milestone marks a significant advancement in transitioning AE’s technology from controlled laboratory

(NYSE:ARE), NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations

KEY HIGHLIGHTS: Homerun Resources has signed a 99-year surface rights agreement, automatically renewable for another 99 years, covering 64 hectares at Fazenda São José, Santa Maria Eterna, Bahia, Brazil, for its industrial projects. Homerun can use the surface rights as collateral in project financing, independently secure permits and licenses, and is protected against changes in

Vancouver, British Columbia–(Newsfile Corp. – December 15, 2025) – Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (“Burcon” or the “Company“), a global technology leader in plant-based protein innovation, is pleased to issue a letter to shareholders from its Chief Executive Officer, Kip Underwood. Dear Fellow Shareholders, 2025 was a transformational year for Burcon, marking the beginning

Vancouver, British Columbia–(Newsfile Corp. – December 15, 2025) – Americore Resources Corp. (TSXV: AMCO) (FSE: 5GP) (OTCQB: AMCOF) (“Americore” or the “Company”) announces that it has completed the first two payments required under its option agreement with Primus Resources (“Primus”) to acquire 42 unpatented lode mining claims contiguous with the Company’s Trinity Silver Project in